Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate

Ileana B Quintero1, Annakaisa M Herrala, César L Araujo

  • 1Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital Laboratory, Helsinki, Finland.

Plos One
|September 17, 2013
PubMed
Summary

Prostate cancer mechanisms were explored using PAP-deficient mice. Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin, affecting vesicular traffic and potentially driving prostate adenocarcinoma development.

Related Concept Videos